Impact of corticosteroid pretreatment in pediatric patients with newly diagnosed B-lymphoblastic leukemia: a report from the Children's Oncology Group

Affiliations

• ¹ Department of Pediatrics and Perlmutter Cancer Center, NYU Langone Health, New York, NY elizabeth.raetz@nyulangone.org.
• ² Department of Pediatrics, Benioff Children's Hospital, and the Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA.
• ³ Department of Biostatistics, Colleges of Medicine, Public Health and Health Professions, University of Florida, Gainesville, FL.
• ⁴ Department of Pediatrics University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, CO.
• ⁵ HARP Pharma Consulting, Mystic, CT.
• ⁶ Department of Pediatrics, Maine Children's Cancer Program, Scarborough, ME.
• ⁷ Department of Genetics, University of Alabama at Birmingham, Birmingham, AL.
• ⁸ Department of Pathology, Wexner Medical Center, Ohio State University, Columbus, OH.
• ⁹ Institute for Genomic Medicine, Nationwide Children's Hospital and Departments of Pathology and Pediatrics, Ohio State University College of Medicine, Columbus, OH.
• ¹⁰ Departments of Pathology and Medicine, University of Washington, Seattle, WA.
• ¹¹ Departments of Pathology and Oncology, Johns Hopkins Medical Institutions, Baltimore, MD.
• ¹² Departments of Pediatrics, UT Southwestern, Dallas, TX.
• ¹³ Department of Pediatrics and the Center for Childhood Cancer Research, Children's Hospital of Philadelphia and Perelman School of Medicine at the University of Pennsylvania, PA, USA.
• ¹⁴ Department of Pediatrics and Perlmutter Cancer Center, NYU Langone Health, New York, NY.